InvestorBrandNetwork (IBN) Content Platform

Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that has developed new-generation power control electronics which expand the capabilities of electric motors and batteries, has appointed Rod Copes, a current director, as interim chair. The move comes as executive chairman Mark Godsy announced he would be leaving the position, effective March 31, 2023. According to the announcement, the transition aligns with Exro’s evolution into series production in Q3 of this year and positioning for a listing on the NASDAQ exchange. “We are also very pleased to announce the appointment of Rod Copes as interim chairman of the Board,” said Exro Technologies CEO Sue Ozdemir in the press release. “Rod’s decades of unique experience in scaling manufacturing operations at both Rivian and Harley-Davidson in the U.S., as well as listing on the NASDAQ exchange, serve as tremendous assets to Exro. On behalf of everyone at Exro and the board, we welcome Rod to his new position and look forward to working with him to continue our efforts to build significant value for our shareholders. . . . “Exro has been very fortunate to have Mark as part of our leadership team. Mark’s entrepreneurial insights have helped to guide the business and establish a framework that sees a thoughtful leadership transition at the right time in the company’s development. On behalf of the board and all our employees, we want to thank him for his years of dedicated service to the board of directors and the company and wish him well in his other endeavours.”

To view the full press release, visit https://ibn.fm/HwOkI

About Exro Technologies Inc.

Exro Technologies is a leading clean-technology company that has developed new-generation power control electronics that change how the world optimizes energy by expanding the capabilities of electric motors and batteries. The company’s innovative technologies serve to bridge the performance-cost gap in e-mobility (Coil Driver(TM)) and stationary energy storage (Cell Driver(TM))), and act to accelerate adoption toward a circular electrified economy by delivering more with less — minimum energy for maximum results. For more information about the company, please visit www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vistagen (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders. The company today announced that the European Patent Office (“EPO”) has granted a patent for AV-101, Vistagen’s oral NMDAR (N-methyl-D-aspartate receptor) glycine site antagonist. “Expanding our patent portfolio for all of our product candidates is an ongoing priority to support our global development and commercialization strategies across our pipeline,” said Shawn Singh, chief executive officer of Vistagen. “AV-101’s potential to inhibit the function of the NMDAR, without fully blocking it like other NMDAR antagonists such as ketamine, anchors our interest in developing it as an innovative therapy for millions of patients affected by CNS disorders involving the NMDAR. This new patent covering our improved and streamlined manufacturing process may result in advantages for getting AV-101 to patients, on our own or potentially with a partner.”

To view the full press release, visit https://ibn.fm/GJ8gl

About VistaGen Therapeutics Inc.

Vistagen is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster-acting and with fewer side effects and safety concerns than those that are currently available for treatment of anxiety, depression and multiple CNS disorders. Vistagen’s pipeline includes multiple product candidates, including fasedienol and itruvone, belonging to a new class of drugs known as pherines, in addition to an oral NMDAR antagonist. Pherines, which are administered as nasal sprays, are designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can beneficially impact key neural circuits in the brain without systemic uptake or direct activity on CNS neurons. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression and several other CNS disorders. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles (“EV”), today announced that its subsidiary Solectrac has debuted a new version of its pioneering e25 electric tractor featuring hydrostatic transmission, a mid-PTO and independent PTO operation. Called the e25H, the new tractor will be available for order in the second half of 2023 along with the currently available e25G. “Solectrac was built on a simple idea—Americans who make a living working the land deserve better than noisy, polluting tractors powered by combustion engines. The success of the e25 shows that our premise is right,” said Mani Iyer, Solectrac CEO. “Now, we are going to make our industry leading e25 electric tractor even better with key updates, so our customers can enjoy all the optionality and utility of an equivalent hydrostatic transmission diesel tractor with much less noise and zero pollution.”

To view the full press release, visit https://ibn.fm/9u4sy

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: accelerating the commercial adoption of electric vehicles. By bringing together vehicles, charging and financing solutions under one roof, Ideanomics is the one-stop partner needed to simplify the transition to and operation of any EV fleet. For more information about the company, visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, today announced its entry into a definitive agreement with a health care-focused U.S. institutional investor. The agreement is for the purchase and sale of 1,570,680 shares of the company’s common stock (or common stock equivalents in lieu thereof) in a registered direct offering and warrants to purchase up to 1,570,680 shares of common stock at a purchase price per share (and accompanying warrant) of $1.91 in a concurrent private placement. The registered direct offering and private placement (together referred to as the “offering”) are priced at-the-market under Nasdaq rules. Subject to satisfaction of customary conditions, the closing of the offering is expected to occur on or about April 10, 2023. The company expects to secure approximately $3 million in gross proceeds and intends to use the net proceeds from the offering for research and development expenses and general corporate purposes, including the preparation of a marketing authorization application and legal expenses. A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.

To view the full press release, visit https://ibn.fm/MWT3r

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company driving groundbreaking studies into clinical programs, which are seeking to address major unmet needs. The company’s primary focus is a novel program to treat inflammatory disorders using anti-TNF (tumor necrosis factor).

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at http://ibn.fm/ATNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

CISO Global Inc. (NASDAQ: CISO), formerly Cerberus Cyber Sentinel Corp., an industry leader in managed cybersecurity and compliance services, recently announced it had achieved SOC 2(R) Type II certification. “Achieving the SOC 2 Type II certification, which was confirmed by an independent audit, is symbolic of CISO’s commitment to providing the highest level of protection and honoring clients’ trust. The certification validates that CISO security controls and data-privacy solutions meet best practices. CISO continues to strengthen its reputation as a managed cybersecurity and compliance provider that can be trusted to secure its customers’ systems. The SOC 2 Type II certification is widely recognized as a symbol of trust and excellence. This certification involves an in-depth review of controls relevant to security, availability, processing integrity, confidentiality and privacy, and provides compliance attestation for service providers worldwide,” a recent article explains. “We believe that the relationship with our clients must be built on trust,” Ashley Devoto, the company’s president and chief information security officer, is quoted as saying. “As companies increase their usage of vendors and partners to perform activities that are core to their business operations and strategies, there is a need for the highest level of confidence and transparency into service providers’ ability to safeguard customer data.”

To view the full article, visit https://ibn.fm/l5aFY

About CISO Global Inc.

CISO is an industry leader as a global cybersecurity and compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations, mitigating continuing and emerging security threats and compliance obligations. Interested investors and shareholders are encouraged to follow Cerberus Sentinel on Twitter and LinkedIn.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PlantX Life (CSE: VEGA) (OTC: PLTXD) (FSE: WNT1), the digital face of the plant-based community, operating a one-stop shop for plant-based products, today announced that it has added Hungry Planet(R) Inc. to its growing roster of brands adopting its e-commerce fulfillment solutions. The addition of Hungry Planet and its chef-crafted plant-based meats further leverages PlantX’s warehousing and logistics capabilities. “Hungry Planet is a huge win for PlantX, not only because their meats taste great, but because the brand targets the large category of ‘flexitarians,’ those people who aim to eat healthy and conscientiously but still indulge in some meat on occasion,” said PlantX CEO Lorne Rapkin. “We are excited to add Hungry Planet’s authentic and complete range of plant-based meats alongside PlantX’s own diverse product assortment as we serve this incremental audience of consumers.”

To view the full press release, visit https://ibn.fm/q2R6R

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is a one-stop shop for plant-based products. With its fast-growing category verticals, PlantX offers customers across North America more than 5,000 plant-based products. PlantX also has other brands in the PlantX portfolio including a juice brand, a coffee company, a plant shop, and brick-and-mortar grocery stores. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. PlantX’s digital presence works to eliminate the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about the company, visit Investor.PlantX.com.

NOTE TO INVESTORS: The latest news and updates relating to PLTXD are available in the company’s newsroom at https://ibn.fm/PLTXD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Friendable (OTC: FDBL), a mobile technology, marketing and software services provider, plans to submit federal and state-level grant applications in the areas of technology, business and commerce. The company made the announcement, noting that the decision to submit the applications is based on the company’s effort to reduce the costs of acquiring capital; FDBL believes this can be accomplished combining grant submissions with traditional fundraising efforts thereby positioning the company to achieve development and growth capital on a less dilutive basis overall, specifically in relationship to its focus on complement U.S. efforts to ban or replace the TikTok app. “Our efforts remain focused as we set our sights on combining grant funding with traditional capital-raising efforts,” said Friendable CEO Robert A. Rositano Jr. in the press release. “It seemed only logical to explore federal and state level technology grants as the U.S. House of Representatives Foreign Committee voted on a bill that would, on the surface, give the U.S. government the ability to impose a full ban on TikTok, under the Emergency Economic Powers Act. Seeing this unfold has led us to believe there is tremendous power in partnering with the U.S. government in any way shape or form, which I believe can start with technology grants that may assist and align with the goals set out by the U.S. Foreign Affairs Committee. I see opportunity on many fronts as we compartmentalize our technology and platforms for the opportunities that are right in our path. Stay tuned for additional white-label market opportunities we’ve identified for our technology as well.”

To view the full press release, visit https://ibn.fm/MA8xI

About Friendable Inc.

Friendable is a mobile technology, marketing and software services provider. The company has developed a base of technologies that have been productized beginning in 2013 and is now leveraging these various technologies to power certain Friendable-owned brands, as well as white-label offerings to companies or entrepreneurs seeking to enter an existing market quickly and cost effectively, leveraging the many years of technology developed and owned by the company. Friendable is also involved in the marketing, development and identification of products, services or brand opportunities the company feels have mass market potential and scalability. Friendable was founded by brothers Robert A. Rositano Jr. and Dean Rositano, who have more than 27 years of experience working together on technology-related ventures. For more information about the company, visit www.Friendable.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases and conditions, has announced enrollment for its phase 1 study of CycloSam(R) in the treatment of bone cancer. The enrollment is for cohort 2, the second grouping of participants, after cohort 1 was completed in February. “We have met all criteria to continue patient enrollment at a higher dose level in the next group of patients,” said QSAM Biosciences CEO Douglas R. Baum. “We are pleased with the safety data and early signs of efficacy, and we are now moving forward with three active clinical trial sites to continue to recruit, screen and enroll participants in this important study evaluating the safety and early efficacy of CycloSam in patients with metastatic bone cancer. With almost $3 million in funding received in our recently completed private placement, and conversion of all of our outstanding convertible notes into common stock, QSAM is in a much stronger position to advance our clinical trials, achieve several important milestones this year, and create a solid foundation for growth and value creation.”

To view the full press release, visit https://ibn.fm/R9hTL

About QSAM Biosciences Inc.

QSAM Biosciences is developing next-generation nuclear medicines for the treatment of cancer and related diseases. QSAM’s initial technology, CycloSam (Samarium-153 DOTMP), is a clinical-stage, bone-targeting radiopharmaceutical developed by IsoTherapeutics Group LLC, pioneers in the nuclear medicine space that also developed the FDA-approved Quadramet(R) (Samarium-153 EDTMP) radiopharmaceutical product. The QSAM team has designed the CycloSam product with the goal of overcoming the limitations of the Quadramet(R) (Samarium-153 EDTMP) product’s FDA-approved indications. QSAM is led by an experienced executive team and board of directors that have completed numerous FDA approvals and multiple successful biotech exits. CycloSam has demonstrated preliminary safety and efficacy in animal studies and a single-patient, FDA-cleared human trial performed in 2020 at the Cleveland Clinic. This nuclear technology uses low specific activity Samarium-153 (resulting in far less undesirable europium impurity) and DOTMP, a chelator that is believed to reduce or eliminate off-target migration and targets sites of high bone turnover, making it, in management’s opinion, an ideal agent to treat primary and secondary bone cancers. Since CycloSam delivers targeted radiation selectively to the skeletal system, it is also believed to be a great potential candidate for future effectiveness in clinical trials in bone marrow ablation as preconditioning for bone marrow transplantation as well as its future clinical trials in procedures to reduce external beam radiation to bone tumors. This multi-patented drug candidate utilizes a radioisotope previously approved by the FDA, combined with a novel targeting chelant, DOTMP, that has demonstrated preliminary increased efficacy and decreased side effects in animal models and veterinary treatment of bone cancer in dogs. Further, CycloSam utilizes a streamlined, just-in-time manufacturing process that is already in place. Given these factors, management believes there is a strong pathway to commercialization for CycloSam. For more information about the company, please visit www.QSAMBio.com

NOTE TO INVESTORS: The latest news and updates relating to QSAM are available in the company’s newsroom at http://ibn.fm/QSAM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the over-the-counter (“OTC”) hearing aid space, today announced the launch of its HearingAssist brand FDA-registered OTC rechargeable hearing aids, including its EZHear Neckband Amplifier and other assorted hearing related supplies on Walgreens.com. “InnerScope continues to execute on its successful B2B sales growth strategy with this latest HearingAssist launch on Walgreens.com,” said Matthew Moore, president and CEO of InnerScope Hearing Technologies. “Walgreens customers can now enjoy the premium rich hearing features offered in the HearingAssist OTC rechargeable hearing aids with prices starting at $499 to $799 a pair compared to similar hearing aids with the same features for thousands of dollars more. With hundreds of thousands of satisfied customers, HearingAssist is America’s No. 1 brand of OTC hearing aids. Furthermore, InnerScope, with its HearingAssist and iHEAR brands of OTC hearing aids, continues to dominate the OTC market with more wholesale distribution and market penetration than any other OTC hearing aid competitor.”

To view the full press release, visit https://ibn.fm/wm4ZP

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories and hearing health-related products (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope, with its B2B business distribution model offering affordable OTC hearing products through major retailers, pharmacy chains and healthcare service companies, breaks through the barriers that prevent access to effective and affordable hearing solutions. In September 2021, InnerScope acquired iHear Medical Inc., a direct-to-consumer (“DTC”) cloud-based hearing solution provider, which provided access to over 40 patents, an R&D facility and a team of engineers. In addition, InnerScope, in November 2021, acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market, with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced and affordable hearing products through Walmart and many other major retailers and pharmacy chains. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Chief Medical Officers, Clinical Research Executives, and Patient Advocacy Experts: attend DGE’s 2nd Diversity in Clinical Trials Summit, taking place May 10-11 in Philadelphia, PA. Join this unique in-person learning and networking experience aimed to remove obstacles in health equity and provide actionable strategies to increase diverse representation in clinical trials.

DGE is bringing together industry-leading experts from global clinical development to discuss the most critical challenges barriers, and methods on how to overcome barriers in order to reduce disparities and achieve health equity. The agenda focuses on increasing representation of underrepresented…

Read More>>

To learn more, please visit https://ibn.fm/r0C5y.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Housing industry and government leaders, specialist delegates, and property experts, are all invited to attend the Future of Housing event taking place on April 25, 2023. Hosted by Sustain SoCal at UCI-Beal Applied Innovation, Irvine, this insightful event will bring the housing community together to nurture best practices and explore ideas.

The Future of Housing event is an assorted continuum of housing stakeholders that collaborate and convene through advocacy, dialogue, education, and research, to develop equitable solutions that serve…

Read More>>

To learn more, please visit https://ibn.fm/qDWDn.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, today announced the release of the latest episode of The Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. Rod Turner, CEO and founder of Manhattan Street Capital, the premier growth capital platform for midsize and startup companies, joined the program to examine the funding platform and share some of the current trends guiding the online capital formation space. “The longer we’re doing this as an industry, the more aware CEOs and CFOs will become regarding when to use an online offering, particularly Reg A+, and which companies are best suited to it. Given how terrible the financial market dynamics are at the moment, we often hear about how the IPO window is closed. That doesn’t mean that the SEC will refuse filings from companies that want to make a public offering… the underwriters say no in a market like this – it’s too expensive, risky and difficult to succeed,” Turner said. “That’s led to a gradually developing method of conducting public offerings called direct listings… It’s been on my radar for some years now to help our client companies make offerings via direct listing, because it’s so much less expensive and you don’t get the door closed in your face for multiple years, which can easily happen in a conventional IPO format.”

To view the full press release, visit https://ibn.fm/nUmdS

About Manhattan Street Capital

Manhattan Street Capital is the premier online fundraising platform focused on helping companies complete IPOs and raise capital using direct listings, Regulation A+, Regulation D and Regulation S, as well as through STO or blockchain offerings that use Reg A+ or Reg D to be legitimate securities offerings. The companies that intend to raise capital with one of these regulations can list their offerings directly on Manhattan Street Capital’s website. Manhattan Street Capital supports the IPO and funding process from start to end, assisting companies with project management and coordination to improve cost efficiency and increase the likelihood of success. For more information, visit the company’s website at www.ManhattanStreetCapital.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Splash Beverage Group (NYSE American: SBEV), a portfolio company of leading beverage brands, announced that it will host a conference call at 10:00 a.m. ET on Tuesday, April 11, 2023, to discuss its previously reported 2022 fourth quarter and full year financial results. Interested parties can join the call by dialing 888-506-0062 (U.S. Toll Free) or 973-528-0011 (international) and entering access code: 766684. In addition, a live webcast will be available and accessible from the Investors’ section of Splash Beverage Group’s website. Attendees are asked to connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. For those unable to join the live event, a replay of the webcast will be available as detailed in the announcement.

To view the full press release, visit https://ibn.fm/3LXOj

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wine by the glass, SALT flavored tequilas, Pulpoloco sangria, and TapouT performance hydration and recovery drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and the Clean Beverage(R) company, today announced that its board of directors approved a 15-for-1 reverse stock split of the company’s authorized and issued and outstanding shares of common stock, which will be effective under Nevada law on April 5, 2023. According to the update, the company’s common stock will continue to trade on the Nasdaq Capital Market under the current trading symbol, WTER, and will be open for trading on a split-adjusted basis on April 5, 2023. As a result of the reverse stock split, the company’s authorized common stock will decrease from 200,000,000 shares, with a par value of US$0.001 per share, to 13,333,333 shares of common stock, with a par value of US$0.001 per share. The number of its issued and outstanding shares of common stock is expected to decrease from approximately 152,080,692 to approximately 10,138,713. The Alkaline Water Company’s authorized preferred stock will not be affected by the reverse stock split. In association with the reverse stock split, the company’s CUSIP number will change to 01643A306 as of April 5, 2023. The company is effectuating the reverse stock split to increase the per share trading price of its common stock in order to satisfy the US$1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market.

To view the full press release, visit https://ibn.fm/HkeCP

About The Alkaline Water Company

The Alkaline Water Company is the Clean Beverage(R) company making a difference in the water you drink and the world we share. Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for Alkaline88. To purchase The Alkaline Water Company’s products online, visit www.Alkaline88.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Predictive Oncology (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, has appointed Christoph Reinhard, PhD, MBA, to its Scientific Advisory Board. Reinhard will join other board members who are thought leaders in respective fields to provide invaluable insight into the company’s scientific initiatives and growth strategy. A leader in oncology translational research, new technologies in drug development and external innovation, Reinhard is acting chief scientific officer for CELLphenomics GmbH, where he facilitates and oversees the process of determining what types of novel drugs and drug combinations might best help future cancer patients with solid tumors. Prior to CELLphenomics GmbH, Reinhard worked at Eli Lilly where spearheaded the company’s Innovative Medicine Initiative in Oncology and was directly involved in the development and implementation of the Partners and Outsourcing Strategy for Lilly Singapore’s drug development and biomarker efforts. He is also the cofounder and director of the board of the Asian Cancer Research Group. “We are fortunate to have someone on our Scientific Advisory Board with such extensive experience in the biopharmaceutical industry with a deep understanding of oncology and translational science,” said Predictive Oncology CEO Raymond F. Vennare in the press release. “Dr. Reinhard’s personal and professional commitment is both impressive and honorable, and his insights into oncology drug development will prove invaluable as we continue to gain momentum with oncology drug development partners around the world.”

To view the full press release, visit https://ibn.fm/bhSjF

About Predictive Oncology Inc.

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Together with the Company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based drug discovery solutions, further complimented by its wholly owned CLIA lab and GMP facilities. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that digital health veteran, Eitan Shay, is joining the company in the newly created position of chief product officer. Shay previously served in product leadership roles at digital health companies Livongo and Teladoc Health, as well as senior leadership roles at Meta Platforms. “Demand for our solution continues to accelerate among payers and employers, and the ability to enhance and scale our intelligent platform is central to our growth strategy,” said Erez Raphael, chief executive officer of Dario. “I could not be more excited to welcome Eitan to the Dario team, as his unique background offers a combination of experience in high-growth commercial product environments along with a deep understanding of consumer engagement. Continuous innovation focused on engagement will be key to our long-term success, and I believe Eitan is the ideal candidate to take on this important role.”

To view the full press release, visit https://ibn.fm/mQwgM

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (“DTx”) company, revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition platform. Its platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. Dario’s user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Flora (NASDAQ: FLGC), a leading cultivator, manufacturer and distributor of global cannabis products and brands, today announced the certification of its Bogotá-based compound formulation laboratory, Flora Lab 4, following the required regulatory inspection by INVIMA (Colombia’s equivalent to the U.S. Food and Drug Administration). According to the update, the inspection certifies the lab as meeting Current Good Manufacturing Practices standards as determined by INVIMA. “We are very pleased to have received CGMP certification and to bring effective medicinal cannabis treatments to patients in Colombia. We applaud the Colombian government’s acknowledgment of the power of this plant by requiring all health insurance providers to cover the cost of medical cannabis. This policy is fundamental to fair access to these medicines for Colombia’s roughly 30 million eligible patients,” said Luis Merchan, chairman and CEO of Flora. “At Flora, we know the future of cannabis relies heavily on the transformation of this unique plant into mainstream medicines, accessible to the populations who need it most. We are proud to be playing a leading role in the progress toward that goal.”

To view the full press release, visit https://ibn.fm/pmhkK

About Flora Growth Corp.

Flora is a global cannabis company dedicated to bringing the benefits of cannabis to people worldwide. Its commitment is to create, master and connect the international cannabis supply chain by setting the standard for world-class cultivation and manufacturing, thoughtful brand development, and rigorous research and development of medical-grade cannabis products that meet the highest standards of quality, safety and efficacy. Flora’s mission is to create a world where the benefits of cannabis are accessible to everyone, and it is working toward that goal by becoming a leading importer and exporter of cannabis to meet demand in every corner of the market. Visit www.FloraGrowth.com or follow @floragrowthcorp on social media for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles, and its subsidiary Solectrac is continuing the rapid expansion of its certified sales and dealer network. The company reported that during Q1 2023, Solectrac added eight certified dealerships with 14 locations in Florida, Texas and California; most new dealers order up to six Solectrac tractors per dealer location for display and customer demonstrations. Solectrac offers marketing and sales support to its dealers. That support includes website development, resources for community engagement, and powerful sales and finance programs along with other tools designed to reach potential customers. “Dealerships are where the magic happens,” said Solectrac CEO Mani Iyer in the press release. “It’s where customers often get their first experience with one of our quiet, clean and powerful electric tractors. That is why I view each dealership location as an important member of the Solectrac community, and I am committed to helping them capture the hearts and minds of customers.”

To view the full press release, visit https://ibn.fm/7dVR5

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: to accelerate the commercial adoption of electric vehicles. By bringing together vehicles, charging and financing solutions under one roof, the company is the one-stop partner needed to simplify the transition to and operation of any EV fleet. For more information about the company, please visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs. The company today announced completion of the training of psychotherapists for its planned phase 2a clinical trial investigating the effects of psilocybin-assisted psychotherapy in the treatment of patients aged 21+ suffering from irritable bowel syndrome (“IBS”) at Massachusetts General Hospital (“MGH”). “We are excited to announce completion of Fluence’s training of psychotherapists for our phase 2a clinical trial in IBS-related pain,” said Jim Gilligan, PhD, chief executive officer of Tryp Therapeutics. “Completion of this training marks a significant step forward in the development of our potentially groundbreaking treatment for patients suffering from this debilitating condition. Collaborating with partners like Harvard/MGH and Fluence, a leader in providing psychotherapeutic training for health professionals administering psychedelic compounds to patients, represents an extraordinary opportunity to advance the field of psychedelic medicine and improve the lives of countless patients.”

To view the full press release, visit https://ibn.fm/OrAav

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida, an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, and a planned phase 2a trial for the treatment of irritable bowel syndrome at Mass General Hospital, all of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Where a preliminary clinical benefit has been demonstrated, subsequent studies are expected to utilize TRP-8803 (IV-infused psilocin), which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Cepton, Inc. recently published its 4Q22 and FY22 financial results
• The company revealed that it had generated FY22 revenues of $7.4 million, up by 65% relative to FY21 results. Furthermore, Cepton guided for FY23 revenues of $15-20 million
• Cepton is at the forefront of lidar technology development, a position they’ve further consolidated with the recent launch of their award-winning Vista® X-120 Plus sensors

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and pioneer within high-performance MMT® lidar solutions, recently announced their financial results for the fourth quarter and full year ending December 31, 2022 (https://ibn.fm/6wp95). The company reported full year 2022 revenues of $7.4 million, within the target guidance provided by Cepton earlier in the year and equivalent to a 65 percent increase year over year. Meanwhile, full year GAAP net income was equivalent to $9.4 million or $0.06 per share. During their release, Cepton provided guidance for their 2023 figures, forecasting full year 2023 revenues to come in at between $15 million to $20 million; meanwhile, the company revealed that they expected 2023 operating expenses to be in line with 2022’s results (i.e., $61.4 million).

The past year has been a momentous one for the company, punctuated by a series of operational and financial highlights. Whether it was unveiling their award-winning Vista® X-120 Plus, the slimmest software definable, top-end automotive lidar for real-time adaptive 3D perception; winning a…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

About TechMediaWire

TechMediaWire (“TMW”) is a tech-focused financial news and content distribution company, one of 50+ brands within IBN, providing: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of corporate communications solutions. As a specialized communications platform with an extensive team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public tech companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By putting a spotlight on the latest and greatest in the tech industry, TMW brings its clients unparalleled visibility, recognition and brand awareness. TMW is where investors come to learn about the next big things in tech and the companies that are making them happen.

To receive SMS text alerts from TechMediaWire, text “TECH” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://TechMediaWire.com/disclaimer

TechMediaWire (TMW)
Los Angeles, CA
www.TechMediaWire.com
212.418.1217 Office
[email protected]

TechMediaWire is part of IBN.

AnPac Bio-Medical Science (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, has announced an asset purchase agreement. The agreement is with Easy Hundred Inc., a U.S.-based e-commerce company in the food-service industry. According to the agreement, AnPac is set to acquire fixed assets of Easy Hundred and Easy Hundred’s intellectual property specifically related to ez100 I, a restaurant supply e-commerce platform; 2Supply, an online marketplace for restaurant suppliers and operators; and 100WAY, which focuses on restaurant reviews and discounts and offers offering effective marketing approaches for restaurants to connect with their customers. The announcement noted that assets include a full set of e-commerce platform source codes, websites, apps, and management systems. “Easy Hundred has some significant shareholders, such as the well-known technology company Menusifu, and has received investments from Amino Capital, Himalaya A Fund III LP, and other institutional investors in the past,” said AnPac Bio-Medical Scienceco-CEO Haohan Xu in the press release. “The acquisition of Easy Hundred’s assets is a strategic initiative to accelerate our business growth in the U.S. food market. Easy Hundred’s one-stop restaurant supplies wholesale platform ez100, online marketplace 2Supply, and restaurant reviews and discounts app 100WAY will provide us with a strong foundation for our business development and expansion in the U.S.”

To view the full press release, visit https://ibn.fm/MLrjF

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of June 30, 2022. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer-screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. The company is entering the business-to-business e-commerce food business with the formation of its wholly owned subsidiary Fresh2 Technology and the acquisition of Fresh2 Ecommerce Inc. For more information about the company, visit www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

TAAT(R) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) has filed its financial statements for first quarter 2023, the three-month period ended Jan. 31, 2023. Highlights of the report include growth of current assets by 2.9% from the last audited financial statements, totaling $11,000,221; sales increased to $23,286,963 from $469,782 (with costs of goods sold of $22,178,902 and $337,817, respectively); and gross profit of $1,108,061 compared to $131,965 in the same period the previous year. The company also reduced expenses by more than 44%. “By significantly reducing the company’s expenses, we have been able to find more efficient ways to grow our branded products,” said TAAT Global Alternatives CEO Michael Saxon in the press release. “Additionally, in the company’s Fiscal Q1 2023, our Ohio-based subsidiary ADCO Distributors Inc. delivered sales growth year-over-year despite challenging headwinds. We thank our retail and institutional shareholders for their continued support as we move forward in 2023.”

To view the full press release, visit https://ibn.fm/DDaSW

About TAAT Global Alternatives Inc.

TAAT Global Alternatives is a vertically integrated consumer product and distribution company, generating more than C$90 million in overall gross revenue annually. TAAT is strategically expanding its product categories including tobacco and reduced-risk alternatives, hemp, kratom and other emerging CPG segments. TAAT facilities include a processing plant in Nevada as well as a distribution center in Canton, Ohio, leveraging existing retail shelf space and pipelines into national wholesale channels. For more information, please visit www.TAATGlobal.com.  

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• The FEXD management team has extensive international experience in developing global fintech platforms and services
• The company in September 2022 announced a business combination with Rana Financial, which provides transfer of funds services between the U.S. and Latin America
• At that same time, FEXD announced the acquisition of Afinoz, a digital lending platform used by India’s leading banks
• In January 2023 the company announced an extension to close its announced business combinations with Rana and Afinoz through April 2023

Fintech Ecosystem Development (NASDAQ: FEXD) is a special purpose acquisition company (“SPAC”) formed for the purpose of effecting one or more business combinations with an intent to focus on the financial technology sector.

The company’s mission is to create and grow a global financial services ecosystem to address unmet mobile money needs in developing and industrialized countries and markets. FEXD plans to achieve this by acquiring and merging with financial technology pioneers that have the potential to help establish…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

• It is estimated that as a result of the COVID-19 pandemic, cybercrime, including theft, data hacking, and destruction, grew by 600%, forcing nearly every industry to embrace new cybersecurity solutions
• Cybercrime is projected to cost companies worldwide an estimated $10.5 trillion annually by 2025, up from $3 trillion in 2015. However, the hefty upfront cost associated with protecting businesses from these attacks is leaving most SMBs vulnerable
• SideChannel acknowledges this issue, and through its team of vCISOs and vCPOs, it is lowering the barrier of entry to access fundamental cybersecurity services, ultimately providing a robust yet affordable solution
• By doing so, the company is playing a pivotal role in improving cybersecurity attack readiness while making robust cybersecurity solutions more accessible and affordable, particularly to SMBs

SideChannel (OTCQB: SDCH), a company founded on the belief that all enterprises, big or small, can have top-tier security guidance at a manageable cost, recognizes the current cost-prohibitive issue with cybersecurity solutions, and seeks to address it by offering affordable and robust cybersecurity support. In addition, the company acknowledges cybersecurity as a growing concern, and the inability of small and mid-sized businesses (“SMBs”) to access associated services is an issue that needs to be addressed, lest many be put out of business.

It is estimated that due to the COVID-19 pandemic, cybercrime, including everything from theft to data hacking and destruction, grew by 600% (https://ibn.fm/CK27W). This has forced nearly every industry to embrace new solutions and adapt quickly to the changing…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Endeavor (NYSE: EDR), the parent company of UFC, was featured in a recent Fox Business article that discussed the company’s deal to acquire World Wrestling Entertainment Inc. (NYSE: WWE) from Vince McMahon and form a new public company. “Endeavor will hold a 51% controlling interest in the new company while WWE shareholders will have a 49% stake. The deal values UFC at $12.1 billion and WWE at $9.3 billion. The announcement comes hours after WWE hosted WrestleMania 39 in Inglewood, California,” the article reads. “This is a rare opportunity to create a global live sports and entertainment pureplay built for where the industry is headed,” Endeavor CEO Ari Emanuel was quoted as saying.

To view the full article, visit https://ibn.fm/X6qPN

About Endeavor Group Holdings Inc.

Endeavor is a global sports and entertainment company, home to many of the world’s most dynamic and engaging storytellers, brands, live events and experiences. The company is comprised of industry leaders including entertainment agency WME; sports, fashion, events and media company IMG; and premier mixed martial arts organization UFC. The Endeavor network specializes in talent representation, sports operations and advisory, event and experiences management, media production and distribution, experiential marketing and brand licensing.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Playgon Games (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR), a SaaS technology company delivering innovative mobile live dealer technology to online gaming operators globally, is reporting key milestones for the March 2023 and the first quarter of 2023. According to the announcement, player activity at its live dealer tables has increased significantly, with March being a record-breaking month in wagering, totaling $145 million, a 30% increase over the best month on record. The daily wagering average for the month set another record, totaling $4.6 million and increasing 31% over the previous best daily wagering average for a month. The quarterly wagering turnover increased 21%, from $275 million to $334 million in Q1 2023, with the average daily wagering turnover spiking from $3 million in Q4 2022 to $3.7 million Q1 2023, representing a 23% increase. “These results are again record-breaking numbers for the company led by our best month since we went live,” said Playgon Games CEO Darcy Krogh in the press release. “Not only was the Q1 up by 23% quarter over quarter, but March shattered our best previous month wagering activity by an impressive 30%. Our integration pipeline is strong, we continue to on-board customers, and our business is scaling. This is an exciting time for Playgon; we look forward to announcing entry into new markets and new partnerships very soon.”

To view the full press release, visit https://ibn.fm/IqgPL

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Playgon’s current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, Playgon products are ideal turnkey solutions for online casinos, sportsbook operators, land-based operators, media groups and big database companies. For more information about the company, please visit www.Playgon.com. 

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

NextPlat Corp. (NASDAQ: NXPL), a global e-commerce provider, is reporting on its financial results for the full year ended Dec. 31, 2022. Financial highlights of the report include revenues of $11.7 million, a 51.3% increase over revenue numbers from 2021, with Q4 2022 revenue coming in at $2.6 million, approximately 26.9% higher than the same period in 2021; annual sales at GTC, the company’s European operation, increased 77.9% with sales at OSC, the company’s North American operation, up more than 34.2%. Gross margins totaled 21.2%, a decrease from 24.0% reported for the previous year, and operating expenses for the full year were approximately $9.7 million. Operational and organizational highlights of the year included the company’s completion of its corporate transition to NextPlat Corp., an expanded focus into the high-growth healthcare market through a $7 million investment and recapitalization of Progressive Care Inc., additions to the leadership teams and the continued strengthening of NXPL subsidiaries’ global partner network. “We are pleased to have ended 2022 with continued record top-line performance,” said NextPlat Corp. executive chair and CEO Charles M. Fernandez in the press release. “2022 was also a year of strategic change at NextPlat, one embodied by the change of our corporate name and expansion of our focus beyond our connectivity and communications offerings towards the delivery of technology solutions and services for healthcare through our investment into Progressive Care. Supported by our expanded global e-commerce capabilities and partnerships in the communications and connectivity markets, we intend to participate in the ongoing digital transformation of healthcare, which is reshaping the entire industry, presenting exciting new opportunities for all stakeholders including providers and patients.”

To view the full press release, visit https://ibn.fm/y3q8w

About NextPlat Corp

NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets for physical and digital assets. The company intends to collaborate with businesses, optimizing the ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications services division through its Global Telesat Communications Ltd. and Orbital Satcom Corp. business units, which offer voice, data, tracking and IoT services to customers worldwide through multiple global storefronts. For more information about the company, please visit www.NextPlat.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the over-the-counter (“OTC”) hearing aid space, today announced its unaudited financial results for the full year ended Dec. 31, 2022. Among the highlights, InnerScope reported consolidated net revenues of $15,284,327, a net profit of $5,575,892 and a positive EBITA of 36% for the 2022 full year. “This profitable year-end 2022 shows we are on the right path continuing to scale and support our growth, especially now with our success with numerous major retailers requesting to sell our products,” said Matthew Moore, CEO of InnerScope Hearing Technologies. “Our B2B strategy and the retailer relationships we built over the last year created strong momentum that will continue through 2023 and beyond. With only a hand full of competitors in this new emerging OTC hearing aid market, we are confident that we can continue to deliver our high-quality affordable OTC hearing aids to the ever-growing demand from all the retailers.”

To view the full press release, visit https://ibn.fm/L1ZK6

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories and hearing health-related products (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope, with its B2B business distribution model offering affordable OTC hearing products through major retailers, pharmacy chains and healthcare service companies, breaks through the barriers that prevent access to effective and affordable hearing solutions. In September 2021, InnerScope acquired iHear Medical Inc., a direct-to-consumer (“DTC”) cloud-based hearing solution provider, which provided access to over 40 patents, an R&D facility and a team of engineers. In addition, InnerScope, in November 2021, acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market, with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced and affordable hearing products through Walmart and many other major retailers and pharmacy chains. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PlantX Life (CSE: VEGA) (OTC: PLTXD) (Frankfurt: WNT1), the digital face of the plant-based community, operating a one-stop shop for plant-based products, today announced its latest collaboration. According to the announcement, the collaboration includes a feature promotion with TiNDLE, the “ridiculously good” plant-based chicken brand and a subsidiary of Next Gen Foods, a high-profile innovator in the alternative protein market. XMarket’s Venice Beach location will feature TiNDLE plant-based chicken products throughout April along with special events, pricing and products. “Next Gen Foods and its co-founders Andre Menezes and Timo Recker are reinventing the food industry with innovation and high-quality products, and we can’t wait to broaden awareness with our loyal customer base,” said PlantX CEO Lorne Rapkin. “Customers will love the healthy and delicious chicken-alternative sandwiches, along with other TiNDLE SKUs. Additionally, delivery is available through Door Dash and Uber Eats. As with our prior promotions, we plan to provide TiNDLE with premium placement and sampling events. Previous promotions have been highly successful, driving traffic to our stores and creating new fans for our partners. We are sure this will be no different.”

To view the full press release, visit https://ibn.fm/UQwkb

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is a one-stop shop for plant-based products. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering delivery service for meals and indoor plants, the company currently has plans underway to expand its product lines to include a juice and coffee company. The company uses its digital platform to build a community of likeminded consumers and, most importantly, to provide education. Its successful enterprise is being built and fortified on partnerships with the top nutritionists, chefs and brands. The company’s digital presence works to eliminate the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life.

NOTE TO INVESTORS: The latest news and updates relating to PLTXD are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Digital Engagement experts, Public Relations officers, and Social Media & Content Management executives, are all invited to attend the 2023 edition of Social Media Strategies Summit – First Responders. The summit will be held from April 12-13, 2023 as a virtual event.

The Social Media Strategies Summit (“SMSI”) will provide a stage to learn about real-life case studies that offer practical insights into generating fresh, creative ideas for social campaigns. SMSI will feature a mix of industry experts who will share advanced social media strategies to grow online communities for…

Read More>>

To learn more, please visit https://ibn.fm/nkVQa.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Siyata Mobile (NASDAQ: SYTA) (TSX.V: SIM), a global provider of innovative Push-to-Talk over Cellular (“PoC”) and cellular signal booster solutions, has received its largest order for the SD7 Handset from a single customer in the education market. The company announced that a school district in the Southwest placed a $600,000-plus order for SD7 handsets and accessories to equip teachers, safety and custodial staff, administration and school bus drivers. “This order represents our single largest SD7 handset order in the education vertical to date,” said Siyata Mobile CEO Marc Seelenfreund in the press release. “This school district recognized the critical role that effective communication tools play in both efficient school operations as well as in times of emergency or crisis. With our SD7 handset, teachers and school staff will be able to initiate and receive talk-group calls, receive private calls and notify first responders in case of an emergency. Our SD7 handset is easy to deploy, can be implemented rapidly with minimal set up, requires no training and no additional maintenance or upgrades to the existing local network. The school district can count on its Push-to-Talk calls being received because the SD7 handset works on a cellular network with ubiquitous coverage and geotracking, regardless of whether staff is in the school, on a field trip or at an event. The education vertical represents our largest market opportunity with more than 115,000 schools and four million teachers in the U.S. alone. School safety is a leading public safety concern, and many schools are seeking technology solutions that can help to create a safer learning environment. We believe that it is absolutely essential that teachers and staff be equipped with next-generation communication tools that enable clear and reliable communication within their school ecosystem, and to and from first responders during an emergency.”

To view the full press release, visit https://ibn.fm/SX53n

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of innovative, next-generation Push-to-Talk over cellular (“PoC”) technology solutions that includes its devices and cellular booster systems. Its portfolio of in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice to increase situational awareness and save lives. Siyata’s portfolio of enterprise-grade and consumer cellular-booster systems enables first responders and enterprise workers to amplify cellular signals in remote areas, inside structural buildings where signals are weak and within vehicles for maximum cellular signal strength possible. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Mydecine (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD. The company today announced that it has improved its financial position, significantly reduced cash burn, increased efficiencies and expanded its intellectual property (“IP”) portfolio. “We’ve spent a significant amount of time refining our core focus to be sustainable, elegant and efficient while still retaining the blue sky that we believe the various drugs we’re developing hold,” said Josh Bartch, Mydecine chairman and CEO. “The context and the goal for Mydecine is to build on data we are seeing from the first generation of psychedelic medicine and to improve the molecules to fit into existing medical infrastructure; we’ve made significant progress towards that goal. Capital market risks have been felt strongly across the industry, forcing companies to pivot or die, as we’ve recently seen. Throughout this time, the Mydecine team has been collectively dedicated, with the vast majority of management deferring cash compensation while continuing to put in 100% effort and focus. We have concentrated on expanding our novel drug development and intellectual property portfolios, as well as finding innovative ways to partner, fund and advance the development of our drug families, while not bearing the total cost associated with it. We look forward to updating the market on our results and evolving partnerships that have occurred in recent months and are ongoing.”

To view the full press release, visit https://ibn.fm/wU0ql

About Mydecine Innovations Group Inc.

Mydecine is a biotechnology company developing the next generation of innovative medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (“PTSD”). The core strategy blends advanced technology with an elaborate infrastructure for drug discovery and development. Mydecine’s dedicated multinational team constantly develops new paths for breakthrough treatment solutions in areas with considerable unmet needs. By collaborating with some of the world’s leading specialists, the company aspires to responsibly speed up the development of breakthrough medications to provide patients with safer and more effective treatment solutions. At the same time, Mydecine’s approach focuses on the next generation of psychedelic medicine by creating innovative compounds with unmatched therapeutic potential through its clinical trial efforts with world-class scientific and regulatory expertise. Founded in 2020, Mydecine is based in Colorado, USA, with extended offices in Alberta, Canada, and Leiden, Netherlands. For more information about the company, visit www.Mydecine.com.

NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, today unveiled its Version 6.0 platform with enhanced and new features. With expanded AI capabilities, the platform is powered by GPT-4 – the same technology behind ChatGPT Plus and Microsoft’s New Bing. “Advancements in generative AI are revolutionizing the way people learn and work,” said Amesite CEO Dr. Ann Marie Sastry. “Amesite’s Version 6.0 platform, which delivers over 99% retention for paid experiences, is the toolset our customers need to provide their learners with AI-assisted learning and engaging, purpose-built learning experiences. Learners who use Amesite Version 6.0 gain real-world experience in leveraging the latest generative AI tools, a skillset which will only grow in demand.”

To view the full press release, visit https://ibn.fm/2zsnU

About Amesite Inc.

Amesite delivers its scalable, customizable, white-labeled online learning platform to universities, businesses, museums and government agencies, enabling them to deliver outstanding digital learning. Amesite provides a single system that combines eCommerce, instruction, engagement, analytics, and administration using best-in-class infrastructure to serve multibillion-dollar online learning markets. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PowerTap Hydrogen Capital (NEO: MOVE) (OTC: MOTNF), a leading provider of on-site hydrogen production technology, entered into a letter of intent (“LOI”) with Newport Realty Group (“NRG”), a California-based real estate development firm, to operate a future PowerTap hydrogen fueling station. According to the announcement, the station will be located in Yermo, California, and will help to provide clean, reliable energy solutions for both light-duty fuel cell electric vehicles (“FCEVs”) and battery electric vehicles (“BEVs”) along with traditional gasoline-powered vehicles; the lease is subject to a definitive agreement. The company noted that NRG currently has plans to develop several retail/energy plazas along Interstate 15, stretching from Los Angeles to Las Vegas and beyond through Nevada and Utah. These sites will feature microgrids for battery electric charging along with petrol stations servicing gasoline and diesel vehicles; the locations will also offer drive-thru restaurants, convenience stores, food halls, public-private lounges and rest areas. “We are thrilled to partner with Newport Realty Group to bring the benefits of clean and sustainable hydrogen energy to consumers and businesses across the west coast,” said PowerTap president and CEO Salim Rahemtulla in the press release. “Our on-site hydrogen production stations will provide a reliable and efficient fuel source for FCEVs and FCETs, while the retail energy centers developed by NRG will offer convenient and accessible charging options for BEVs and traditional gasoline-powered vehicles.”

To view the full press release, visit https://ibn.fm/82Nfo

About PowerTap Hydrogen Capital Corp.

PowerTap Hydrogen, through its wholly owned subsidiary PowerTap Hydrogen Fueling Corp., is focused on installing hydrogen production and dispensing fueling infrastructure in the United States. PowerTap’s patented solution has been developed over 20 years. PowerTap is now commercializing its third-generation blue-hydrogen product, which will focus on the refueling needs of the automotive and long-haul trucking markets that lack hydrogen fueling infrastructure. For more information about the company, please visit www.CleanPower.Capital.

NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at https://ibn.fm/MOTNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, is reporting financial results for its fourth quarter and full year period ended Dec. 31, 2022. Highlights of the report include Q4 revenues of $4.79 million compared to $3.06 million, a 56% increase over the same period the previous year, with full-year gross revenues increasing 61%, from $11.8 million in 2021 to $19 million in 2022. Fourth-quarter gross margin increased to $3.3 million with full-year gross margin totaling $5.9 million compared to $3.9 million in the prior year. Q4 net loss decreased to $4.8 million from $6.2 million in the previous year with full-year net loss also decreasing from $29 million in 2021 to $21.7 million in 2022. As of Dec. 31, 2022, the company reported total cash and cash equivalents of $4.4 million, up from $4.2 million the year before. “Our 2022 full year results reflect solid progress in the execution of our long-term business plan,” said Splash Beverage CEO Robert Nistico in the press release. “It was our first full year of operating results after our mid-year 2021 public offering and uplisting of our shares to the NYSE American. We’ve grown gross revenue to more than $19 million while continuing to enhance gross margins. We are doing the work internally to rachet down cost of goods and capture efficiencies. We have made new investments in marketing and personnel in support of our brand’s growth and still successfully narrowed net losses on a year over year basis. These investments resulted in significant new retail chain activity toward the back half of 2022 strengthening the base of our revenues as we head into 2023. We’ve successfully accessed the capital and credit markets when we needed to grow inventory, and all the while we have been adding to our top tier distribution network across all of our brands and, most importantly, with some of the largest names in the retail chain industry. As I’ve said many times, in the beverage industry, distribution is key, if you can’t put product on the shelves, you won’t succeed. We’ve invested heavily to build the infrastructure needed to put product through our distribution networks and into the hands of our consumers, and we expect the combination of infrastructure and distribution to translate into continued fast revenue growth shortening our path on our march toward profitability.”

To view the full press release, visit https://ibn.fm/z4jIO

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wine by the glass, SALT flavored tequilas, Pulpoloco sangria, and TapouT performance hydration and recovery drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, please visit www.SplashBeverageGroup.com. 

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, is reporting that its board of directors authorized the repurchase of up to $2 million worth of shares of the company’s common stock. According to the announcement, the repurchase program will expire on Sept. 29, 2023, or when a maximum of $2 million has been repurchased, or when the program is discontinued by the board. In addition, the program may be suspended, terminated or modified for any reasons, including market conditions, cost of repurchasing shares, availability of alternative investment opportunities, liquidity, or other factors deemed appropriate; the authorization of the repurchase program does not obligate the company to purchase any particular number of shares. The company also noted that the program is subject to future extensions based on the discretion of the board. “We believe the repurchase program may provide numerous benefits to the company and its stockholders including, among others, mitigation of overhang on the market for the company’s common stock; attractive use of the company’s capital to repurchase shares at current prices; a more tax-efficient way of returning capital to shareholders compared to declaring cash dividends; and accretion to earnings per share,” said Golden Matrix Group CEO Anthony Brian Goodman in the press release.

To view the full press release, visit https://ibn.fm/K51QM

About Golden Matrix Group Inc.

Golden Matrix Group, based in Las Vegas, Nevada, is an established B2B and B2C gaming technology company operating across multiple international markets. The B2B division of Golden Matrix develops and licenses proprietary gaming platforms for its extensive list of clients and RKings, its B2C division, operates a high-volume ecommerce site enabling end users to enter paid-for competitions on its proprietary platform in authorized markets. The company’s sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with current U.S. law. For more information about the company, visit www.GoldenMatrix.com

NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Flora Growth (NASDAQ: FLGC), a leading cultivator, manufacturer and distributor of global cannabis products and brands, has announced its 2022 financial and operating results for the fiscal year ended Dec. 31, 2022. Highlights of the report include $37.2 million in revenue for the year, which is a year-over-year increase of 314% and includes record revenue for the fourth quarter, which totaled $11.5 million, a 7% sequential increase over Flora Growth’s third quarter. Gross profit for the year increased 494%, from $2.4 million in 2021 to $14.4 million in 2022. According to the company, its 2023 revenue guidance will remain between $90 to $105 million. “In 2022, we not only met our revenue guidance but reported both quarterly and annual record revenue,” said Flora Growth chair and CEO Luis Merchan in the press release. “This accomplishment was thanks to the successful completion and integration of our M&A transactions, the compelling value proposition of our products in our house of brands and the operational milestones we achieved throughout the year. It is important to note that we have accomplished all this despite having to navigate one of the most hostile business environments to date, especially for the cannabis industry. Nonetheless, we achieved both quarterly and annual record revenue, improved margins and increased our gross profits — all while cutting costs and improving operational efficiencies. Today, I remain more confident than ever in Flora’s opportunity to not only be one of the largest players in the international cannabis industry but to change the global landscape of cannabis. I am proud to reaffirm the 2023 revenue guidance we shared earlier in the year of between $90 million and $105 million.”

To view the full press release, visit https://ibn.fm/oApK9

About Flora Growth Corp.

Flora Growth Corp. is a global cannabis company dedicated to bringing the benefits of cannabis to people worldwide. Our commitment is to create, master and connect the international cannabis supply chain by setting the standard for world-class cultivation and manufacturing, thoughtful brand development, and rigorous research and development of medical-grade cannabis products that meet the highest standards of quality, safety, and efficacy. Our mission is to create a world where the benefits of cannabis are accessible to everyone, and we are working toward that goal by becoming a leading importer and exporter of cannabis to meet demand in every corner of the market. For more information about the company, please visit www www.FloraGrowth.com

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

AnPac Bio-Medical Science (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, has entered into a securities purchase agreement with certain institutional investors. The agreement outlines investors’ plans to purchase $3 million of ANPC’s American Depositary Shares (“ADSs”) and prefunded warrants to purchase ADSs along with warrants to purchase ADSs in a registered direct offering. According to the announcement, AnPac will sell a total of 625,000 ADSs at $4 per ADS, with pre-funded warrants exercisable for 125,000 ADSs and warrants exercisable for 750,000 ADSs. The company anticipates using the funds from the offering for the advancement of its research and development activities as well as working capital and general corporate purposes.

To view the full press release, visit https://ibn.fm/21yQV

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of June 30, 2022. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer-screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. The company intends to enter the business-to-business e-commerce food business with the formation of its wholly owned subsidiary Fresh2 Technology and the acquisition of Fresh2 Ecommerce Inc. For more information about the company, visit www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, has been approved to dual list its shares on Upstream, a MERJ Exchange market. According to the announcement, trading on Upstream is scheduled to begin on April 6, 2023, using the ticker symbol GNS; the company will continue to trade on NYSE American. The dual listing on Upstream provides the company with a global, digital-first investor base with an array of trade options, including USDC digital currency, credit, debit, PayPal and USD. “Building shareholder value is an ongoing goal of ours,” said Genius Group CEO Roger Hamilton in the press release. “We believe a dual listing on Upstream will unlock liquidity and enhance price discovery for our shareholders.”

To view the full article, visit https://ibn.fm/Eh02B

About Genius Group Limited

Genius Group is a world leading entrepreneur edtech and education group, with a mission to disrupt the current education model with a student-centered, lifelong learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. The group has a base of 4.3 million users in 200 countries. For more information, please visit www.GeniusGroup.net

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DGE invites Clinical Innovation and Development experts, Patient Recruitment specialists, and Clinical Safety/Regulatory Affairs officers, to attend the 7th Decentralized & Hybrid Clinical Trials Summit, to be held in Philadelphia, PA, May 10-11, 2023.

Decentralized and hybrid clinical trials remove geographic hurdles and increase patient participation rates and diversity – as long as the teams are aptly trained and have the right…

Read More>>

The 7th Decentralized & Hybrid Clinical Trials Summit is the industry’s most reliable conference for

To learn more, please visit https://ibn.fm/IBbV1

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

TAAT(R) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) is reporting that it will be filing its financial statements for Q1 2023, the three-month period ending Jan. 31, 2023. The company plans to file the information on Monday, April 3, 2023. The company also announced that it has terminated the definitive agreement to acquire the Break Free(TM) mobile application and associated working capital from Boksburg Ventures Inc., a proposed transaction that was announced by the company earlier this month.

To view the full press release, visit https://ibn.fm/71zuY

About TAAT Global Alternatives Inc.

TAAT Global Alternatives is a vertically integrated consumer product and distribution company, generating more than C$90 million in overall gross revenue annually. TAAT is strategically expanding its product categories including tobacco and reduced-risk alternatives, hemp, kratom and other emerging CPG segments. TAAT facilities include a processing plant in Nevada as well as a distribution center in Canton, Ohio, leveraging existing retail shelf space and pipelines into national wholesale channels. For more information, please visit www.TAATGlobal.com.  

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork